NCT07524062 The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery
| NCT ID | NCT07524062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Wound Healing |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-06-15 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates whether infrared thermography, a harmless and non-invasive thermal camera technique, can help monitor how surgical wounds heal after skin surgery. The goal is to detect wound problems earlier, such as infection or delayed healing, and to support doctors in making timely clinical decisions.
Eligibility Criteria
Inclusion Criteria: 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Adult subjects (\>18 years of age) at time of enrolment 3. Patients undergoing a surgical excision under local anesthesia 4. Indications of the excisions were skin lesions suspected to be malignant, skin lesions confirmed to be malignant via prior biopsy Exclusion Criteria: 1. Patient has history of pre-existing diabetes type I and II 2. Patients with pre-existing chronic wound problems 3. Patients with renal dysfunction, 4. Patients with venous insufficiency confirmed via radiographic imaging 5. Patients who received radiotherapy in the affected area in the past 6. Patients with chronic steroid use in the past (\> 3 months) or a immunosuppressant medication history 7. Female who is pregnant
Contact & Investigator
Annemiek Leeman, Prof. Dr.
PRINCIPAL INVESTIGATOR
UZLeuven, Department of Dermatology
Frequently Asked Questions
Who can join the NCT07524062 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Wound Healing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07524062 currently recruiting?
Yes, NCT07524062 is actively recruiting participants. Contact the research team at annemiek.leeman@uzleuven.be for enrollment information.
Where is the NCT07524062 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT07524062 clinical trial?
NCT07524062 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Annemiek Leeman, Prof. Dr. at UZLeuven, Department of Dermatology. The trial plans to enroll 120 participants.